Literature DB >> 25640554

The relation of matrix metalloproteinase 1, 2, 3 expressions with clinical and radiological findings in primary and recurrent lumbar disc herniations.

Seyma Ozkanli1, Tuncay Kaner, Mustafa Efendioglu, Recep Basaran, Mehmet Senol, Ebru Zemheri, Ahmet Ferruh Gezen.   

Abstract

AIM: In this study, our aim was to examine if matrix metalloproteinase expressions (MMP-1, MMP-2, MMP-3) in patients operated with a lumbar disc hernia diagnosis are different in terms of clinical and neuroradiological findings.
MATERIAL AND METHODS: The study included 80 patients treated with micro discectomy for lumbar disc hernia. Degeneration was scored via magnetic resonance (MR) images. MMP-1, MMP-2, and MMP-3 antibodies were used for immunohistochemical evaluation of degenerated disc materials. MMP expressions were compared between primary and recurrent cases, and correlation analysis was conducted.
RESULTS: Discectomy material showed higher expression of MMP-1 and MMP-3 in cases of recurrent lumbar disc herniation than in primary herniation. There was no significant relationship between MMP expression and MR degeneration score.
CONCLUSION: MMP-1 and MMP-3 expressions were significantly higher in recurrent cases in terms of magnetic resonance degeneration score. We assume that the higher co-expression of MMP-1 and MMP-3 might be used in targeted treatment regiemens in patients with recurrent LDH.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25640554     DOI: 10.5137/1019-5149.JTN.11276-14.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  8 in total

1.  Gene-Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus.

Authors:  Wei Chen; Hao Chen; Dandan Zheng; Hongbo Zhang; Lianfu Deng; Wenguo Cui; Yuhui Zhang; Hélder A Santos; Hongxing Shen
Journal:  Adv Sci (Weinh)       Date:  2019-10-07       Impact factor: 16.806

2.  MicroRNA-25-3p therapy for intervertebral disc degeneration by targeting the IL-1β/ZIP8/MTF1 signaling pathway with a novel thermo-responsive vector.

Authors:  Yong Huang; Leizhen Huang; Li Li; Zhishen Ge; Ganjun Feng; Limin Liu; Yueming Song
Journal:  Ann Transl Med       Date:  2020-11

3.  Significance of Immune-Related Genes in the Diagnosis and Classification of Intervertebral Disc Degeneration.

Authors:  Bo Wu; Xinzhou Huang; Mu Zhang; Wei Chu
Journal:  J Immunol Res       Date:  2022-08-30       Impact factor: 4.493

4.  The expression of metalloproteinases in the lumbar disc correlates strongly with Pfirrmann MRI grades in lumbar spinal fusion patients.

Authors:  Sanjay S Aripaka; Rachid Bech-Azeddine; Louise M Jørgensen; Jens D Mikkelsen
Journal:  Brain Spine       Date:  2022-02-05

5.  Motor control exercise for symptomatic lumbar disc herniation: protocol for a systematic review and meta-analysis.

Authors:  Mohammad Reza Pourahmadi; Morteza Taghipour; Ismail Ebrahimi Takamjani; Mohammad Ali Sanjari; Mohammad Ali Mohseni-Bandpei; Abbas Ali Keshtkar
Journal:  BMJ Open       Date:  2016-09-27       Impact factor: 2.692

Review 6.  The Immune Privilege of the Intervertebral Disc: Implications for Intervertebral Disc Degeneration Treatment.

Authors:  Zhen Sun; Bing Liu; Zhuo-Jing Luo
Journal:  Int J Med Sci       Date:  2020-02-24       Impact factor: 3.738

7.  Polymorphism of IL-1β rs16944(T/C) Associated with Serum Levels of IL-1β and Subsequent Stimulation of Extracellular Matrix Degradation Affects Intervertebral Disk Degeneration Susceptibility.

Authors:  Zhao Wang; Xiaoxia Song; Qingbo Fang; Weige Xia; Aihua Luo
Journal:  Ther Clin Risk Manag       Date:  2021-05-24       Impact factor: 2.423

8.  Mangiferin Alleviates Mitochondrial ROS in Nucleus Pulposus Cells and Protects against Intervertebral Disc Degeneration via Suppression of NF-κB Signaling Pathway.

Authors:  Haichao Yu; Guowei Hou; Jiankang Cao; Yanyu Yin; Yunpeng Zhao; Lei Cheng
Journal:  Oxid Med Cell Longev       Date:  2021-06-11       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.